This book investigates the complex processes and challenges involved in acquiring drugs and biologics for the defense against chemical and biological warfare. Richard A. Rettig, a noted scholar in the field of health policy and research, examines the historical context and the specific governmental and scientific hurdles that have influenced the development and procurement of countermeasures. The work analyzes the interplay between scientific innovation, regulatory frameworks, and national security imperatives in shaping the availability of critical medical supplies for defense purposes.

This work is recognized for its detailed examination of a critical, yet often overlooked, aspect of national security. The analysis provides a thorough understanding of the governmental and scientific mechanisms required to secure vital medical defenses against biological and chemical threats. It serves as an important resource for policymakers, researchers, and anyone interested in the intersection of public health, science, and defense.